Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-04-21

Clinical Trial Update: Inositol and Omega-3 Fatty Acids in Pediatric Mania [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating inositol and omega-3 fatty acids for pediatric bipolar spectrum disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pediatric Bipolar Spectrum Disorders | Phase 4 | Status: COMPLETED | Results posted: 2020-04-21